{"id":"https://openalex.org/W4282964194","doi":"https://doi.org/10.1158/1538-7445.am2022-5377","title":"Abstract 5377: Decitabine sensitizes diffuse large B cell lymphoma cells to venetoclax","display_name":"Abstract 5377: Decitabine sensitizes diffuse large B cell lymphoma cells to venetoclax","publication_year":2022,"publication_date":"2022-06-15","ids":{"openalex":"https://openalex.org/W4282964194","doi":"https://doi.org/10.1158/1538-7445.am2022-5377"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2022-5377","doi":"https://doi.org/10.1158/1538-7445.am2022-5377","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-5377","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063755644","display_name":"Matthew Steven Davids","orcid":"https://orcid.org/0000-0003-4529-2003","observed_orcids":["https://orcid.org/0000-0003-4529-2003"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew S. Davids","raw_affiliation_strings":["1Dana Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056994035","display_name":"Fen Zhu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fen Zhu","raw_affiliation_strings":["1Dana Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063159222","display_name":"Stephen Jun Fei Chong","orcid":"https://orcid.org/0000-0002-9188-7131","observed_orcids":["https://orcid.org/0000-0002-9188-7131"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen J. Chong","raw_affiliation_strings":["1Dana Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088077600","display_name":"Jennifer Leigh Crombie","orcid":"https://orcid.org/0000-0003-3445-5129","observed_orcids":["https://orcid.org/0000-0003-3445-5129"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Crombie","raw_affiliation_strings":["1Dana Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018834596","display_name":"Liam R. Hackett","orcid":"https://orcid.org/0000-0002-3330-2369","observed_orcids":["https://orcid.org/0000-0002-3330-2369"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Liam Hackett","raw_affiliation_strings":["1Dana Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054523541","display_name":"May C. Collins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"May C. Collins","raw_affiliation_strings":["1Dana Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210117453"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"12_Supplement","first_page":"5377","last_page":"5377"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.6352999806404114,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.6352999806404114,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.2720000147819519,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.053700000047683716,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9810000061988831},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.890999972820282},{"id":"https://openalex.org/keywords/decitabine","display_name":"decitabine","score":1.0},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.8889999985694885},{"id":"https://openalex.org/keywords/bcl-2-dependence","display_name":"BCL-2 dependence","score":0.9399999976158142},{"id":"https://openalex.org/keywords/bh3-profiling","display_name":"BH3 profiling","score":0.9039999842643738},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7590000033378601},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6809999942779541},{"id":"https://openalex.org/keywords/mcl-1-inhibition","display_name":"MCL-1 inhibition","score":0.6919999718666077},{"id":"https://openalex.org/keywords/bcl-xl-inhibition","display_name":"BCL-XL inhibition","score":0.8870000243186951},{"id":"https://openalex.org/keywords/double-hit-lymphoma","display_name":"double-hit lymphoma","score":0.8679999709129333},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.7710000276565552},{"id":"https://openalex.org/keywords/mitochondrial-stress","display_name":"mitochondrial stress","score":0.3790000081062317},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.47099998593330383}],"concepts":[{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.9290591478347778},{"id":"https://openalex.org/C2780235182","wikidata":"https://www.wikidata.org/wiki/Q1181878","display_name":"Decitabine","level":5,"score":0.8716671466827393},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6440714001655579},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5999210476875305},{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.5896475911140442},{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.5710208415985107},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.43171966075897217},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.42549216747283936},{"id":"https://openalex.org/C18431079","wikidata":"https://www.wikidata.org/wiki/Q1502169","display_name":"Gene expression profiling","level":4,"score":0.4166482985019684},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.33596205711364746},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.30571842193603516},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.22987103462219238},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.22765392065048218},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.20043721795082092},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.151249498128891},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.12514030933380127}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2022-5377","doi":"https://doi.org/10.1158/1538-7445.am2022-5377","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-5377","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4385514479","https://openalex.org/W4399286909","https://openalex.org/W4322619333","https://openalex.org/W3215243369","https://openalex.org/W7212085315","https://openalex.org/W2474000835","https://openalex.org/W7165007460","https://openalex.org/W2480471866","https://openalex.org/W2979320157","https://openalex.org/W3045352057"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"Despite":[2],"recent":[3],"advances":[4],"in":[5,39,67,105,119,193,220,250,304,352,395,411,412],"the":[6,111,114,131,139,192,213,248,274,282,308,326,360,380,447],"therapy":[7],"of":[8,71,113,134,141,197,209,216,276,284,310,320,329,335,359,408,446],"diffuse":[9,435],"large":[10,436],"B":[11,30,437],"cell":[12,31,155,162,168,186,293,349,438],"lymphoma":[13,32,182,439],"(DLBCL),":[14],"many":[15],"patients":[16],"are":[17,26],"still":[18],"not":[19],"cured,":[20],"and":[21,53,138,159,179,199,239,267,286,291,346,366,401],"therefore":[22],"new":[23],"therapeutic":[24],"combinations":[25],"needed.":[27],"The":[28,166,387],"anti-apoptotic":[29,145,218],"2":[33],"(BCL-2)":[34],"gene":[35,54],"is":[36,406],"commonly":[37],"dysregulated":[38],"DLBCL":[40,106,167,221,226,263,277,305,353,384,391],"due":[41],"to":[42,65,76,84,87,129,190,231,279,300,348,393,441],"various":[43,144],"mechanisms":[44,334],"such":[45],"as":[46,281],"chromosomal":[47],"translocation":[48],"t(14;18)(q32.3;q21.3),":[49],"copy":[50],"number":[51],"alterations":[52],"amplifications;":[55],"however,":[56],"targeting":[57],"BCL-2":[58,146,269,402],"with":[59,90,117,212],"a":[60,69,78,126,311],"selective":[61],"inhibitor,":[62],"venetoclax,":[63,280],"led":[64],"response":[66,86],"only":[68,323],"minority":[70],"patients.":[72],"Thus,":[73],"we":[74,94,109,205,258,316,338,369],"sought":[75],"identify":[77],"novel":[79],"combination":[80,283,373,405],"partner":[81],"for":[82,136,265,383,450],"venetoclax":[83,118,287,394,442],"improve":[85],"therapy.":[88],"Previously":[89],"dynamic":[91,243],"BH3":[92,124,203,233,244],"profiling,":[93,125,204],"found":[95,206,259,317,339,370],"that":[96,260,318,340,371],"DNA":[97,344],"hypomethylating":[98],"agents":[99],"(HMA)":[100],"could":[101],"increase":[102,301],"BCL2":[103],"dependence":[104,140,208],"cells.":[107,354,385],"Here,":[108],"investigate":[110,191],"activity":[112,196,328],"HMA":[115,388],"decitabine":[116,198,261,272,285,341,356,389],"DLBCL.":[120],"Methods:":[121],"We":[122],"utilized":[123],"functional":[127],"assay":[128],"assess":[130],"mitochondrial":[132],"priming":[133,251,400],"cells":[135,142,227,264,278,392,440],"apoptosis":[137,266,290],"on":[143],"family":[147],"proteins.":[148],"Other":[149],"standard":[150],"techniques":[151],"included":[152],"Western":[153,224],"blot,":[154],"cycle":[156,350],"(BrdU/7-AAD),":[157],"CellTiter-Glo,":[158],"Seahorse":[160],"XF":[161],"mito":[163],"stress":[164],"test.":[165],"lines":[169,187],"(TMD8,":[170],"HBL1,":[171],"OCI-Ly3,":[172],"OCI-Ly1,":[173],"Karpas":[174],"422,":[175],"SUDHL4,":[176],"Toledo,":[177],"OCI-Ly7)":[178],"double":[180],"hit":[181],"(DHL)":[183],"patient-derived":[184],"xenograft":[185],"were":[188,228],"used":[189],"vitro":[194,396],"anti-cancer":[195,327,333],"venetoclax.":[200],"Results:":[201],"Through":[202],"heterogenous":[207],"DLBCL,":[210],"consistent":[211],"variable":[214],"expression":[215,309],"multiple":[217],"proteins":[219],"assessed":[222],"by":[223,253,306],"blot.":[225],"less":[229],"sensitive":[230],"single":[232],"mimetic":[234],"treatment":[235],"(venetoclax,":[236],"S63":[237],"(MCL-1i)":[238],"A133":[240],"(BCL-xLi)).":[241],"Using":[242],"profiling":[245],"(which":[246],"assesses":[247],"change":[249],"induced":[252],"ex":[254],"vivo":[255,413],"drug":[256],"treatment),":[257],"primes":[262],"increases":[268,273],"dependence.":[270,403],"Consequently,":[271],"sensitivity":[275],"synergistically":[288],"induces":[289,343],"suppresses":[292,375],"proliferation.":[294],"Decitabine":[295,433],"has":[296],"previously":[297],"been":[298],"shown":[299],"TGF-\u03b2":[302,321],"signaling":[303,322],"restoring":[307],"downstream":[312],"target,":[313],"SMAD1.":[314],"Interestingly,":[315],"inhibition":[319],"partially":[324],"antagonizes":[325],"decitabine,":[330],"implicating":[331],"other":[332],"decitabine.":[336],"Indeed,":[337],"also":[342,374],"damage":[345],"leads":[347],"arrest":[351],"Furthermore,":[355],"promotes":[357],"activation":[358],"key":[361],"apoptotic":[362,399],"effector":[363],"proteins,":[364],"BAK":[365],"BAX.":[367],"Additionally,":[368],"this":[372],"oxidative":[376],"phosphorylation,":[377],"thus":[378],"restricting":[379],"energy":[381],"supply":[382],"Conclusions:":[386],"sensitizes":[390,434],"through":[397],"increasing":[398],"This":[404],"worthy":[407],"further":[409],"study":[410],"model":[414],"systems.":[415],"Citation":[416],"Format:":[417],"Matthew":[418],"S.":[419],"Davids,":[420],"Fen":[421],"Zhu,":[422],"Stephen":[423],"J.":[424],"Chong,":[425],"Jennifer":[426],"Crombie,":[427],"Liam":[428],"Hackett,":[429],"May":[430],"C.":[431],"Collins.":[432],"[abstract].":[443],"In:":[444],"Proceedings":[445],"American":[448],"Association":[449],"Cancer":[451,462],"Research":[452],"Annual":[453],"Meeting":[454],"2022;":[455],"2022":[456],"Apr":[457],"8-13.":[458],"Philadelphia":[459],"(PA):":[460],"AACR;":[461],"Res":[463],"2022;82(12_Suppl):Abstract":[464],"nr":[465],"5377.":[466]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-06-17T00:00:00"}